SLAM
JAZZ icon

Swiss Life Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Swiss Life Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 655
2026
Q1 		– Sell
-4,041
Closed -$687K – 1564
2025
Q4 		$687K Buy
4,041
+1,349
+50% +$207K ﹤0.01% 708
2025
Q3 		$355K Buy
+2,692
New +$323K ﹤0.01% 831
2023
Q4 		– Sell
-14,984
Closed -$1.94M – 646
2023
Q3 		$1.94M Buy
+14,984
New +$2M 0.03% 479
2023
Q1 		– Sell
-21,053
Closed -$3.37M – 623
2022
Q4 		$3.37M Buy
21,053
+219
+1% +$32.1K 0.06% 353
2022
Q3 		$2.78M Buy
20,834
+1,068
+5% +$162K 0.05% 390
2022
Q2 		$3.1M Buy
19,766
+58
+0.3% +$8.93K 0.05% 374
2022
Q1 		$3.06M Buy
19,708
+1,324
+7% +$192K 0.04% 374
2021
Q4 		$2.34M Sell
18,384
-1,754
-9% -$231K 0.03% 414
2021
Q3 		$2.62M Sell
20,138
-15,828
-44% -$2.39M 0.04% 388
2021
Q2 		$6.44M Buy
35,966
+15,240
+74% +$2.64M 0.07% 280
2021
Q1 		$3.4M Buy
20,726
+619
+3% +$102K 0.05% 369
2020
Q4 		$3.31M Hold
20,107
– – 0.05% 368
2020
Q3 		$2.86M Sell
20,107
-9,619
-32% -$1.19M 0.04% 281
2020
Q2 		$3.28M Buy
29,726
+11,213
+61% +$1.24M 0.05% 234
2020
Q1 		$1.85M Sell
18,513
-2,907
-14% -$376K 0.04% 321
2019
Q4 		$3.2M Buy
21,420
+349
+2% +$47.5K 0.06% 250
2019
Q3 		$2.7M Buy
21,071
+2,862
+16% +$384K 0.04% 289
2019
Q2 		$2.59M Buy
18,209
+2,383
+15% +$320K 0.03% 273
2019
Q1 		$2.26M Buy
+15,826
New +$2.06M 0.03% 272
2018
Q4 		– Sell
-10,760
Closed -$1.81M – 332
2018
Q3 		$1.81M Buy
10,760
+1,794
+20% +$309K 0.02% 345
2018
Q2 		$1.55M Buy
+8,966
New +$1.47M 0.02% 346
2017
Q1 		– Sell
-3,448
Closed -$376K – 481
2016
Q4 		$376K Hold
3,448
– – 0.01% 395
2016
Q3 		$418K Buy
3,448
+1,222
+55% +$165K 0.01% 387
2016
Q2 		$314K Buy
+2,226
New +$328K 0.01% 294

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Swiss Life Asset Management's JAZZ Position: Q2 2026 in Review

Swiss Life Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 0 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #655.

Swiss Life Asset Management first reported a position in JAZZ in Q2 2016 and has held it in 24 quarters since. The position peaked at $6.44M in Q2 2021. 420 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Swiss Life Asset Management held 0 shares of Jazz Pharmaceuticals worth $1.21M as of Q2 2026.
  • Swiss Life Asset Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #655 holding.
  • Swiss Life Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2016 and has held it in 24 quarters since.
  • Swiss Life Asset Management's Jazz Pharmaceuticals position peaked at $6.44M in Q2 2021.
  • 420 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.